The global market for Open Loop Artificial Pancreas was valued at US$ 1530 million in the year 2024 and is projected to reach a revised size of US$ 2567 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Open loop artificial pancreas is a relatively simple but effective medical device for diabetes management. Its core function is to simulate the insulin secretion mechanism of healthy pancreas. Unlike closed-loop systems, open-loop artificial pancreas does not have blood glucose sensors, but is mainly composed of two core parts: a microcomputer and an insulin injection pump. This system design simplifies its structure, reduces its size, and makes it easier for patients to carry and use. The operating mechanism of open-loop artificial pancreas is based on preset programs rather than real-time blood glucose monitoring data. The patient's blood glucose concentration data needs to be manually input into the system, and the microcomputer calculates the insulin dose and rate parameters that need to be infused based on these input data and preset algorithms. Subsequently, the insulin injection pump automatically injects the corresponding amount of insulin into the patient's body according to the calculated parameters.
The global open loop artificial pancreas market has maintained a growth trend in recent years. With the acceleration of the aging process of the population and the change of lifestyle, the number of patients with diabetes has increased rapidly, providing a huge potential demand for artificial pancreas. The technological breakthroughs in the field of artificial pancreas are mainly reflected in miniaturization, intelligence, and materials science, which indirectly promote the improvement and upgrading of open-loop systems. The changes in medical policies and reimbursement systems have a profound impact on the market landscape. In many developed countries, artificial pancreas is included in the coverage of medical insurance, which greatly reduces the economic burden on patients and promotes the increase of market penetration. With the popularization of health education and the wide spread of medical information, diabetes patients began to seek more accurate and convenient blood glucose management solutions. The open-loop artificial pancreas is between traditional injection and fully automated closed-loop systems, balancing performance and price, and has become the choice of many patients. The global market competition pattern is relatively clear, with multiple companies engaging in fierce competition. Tandem Diabetes Care, Johnson&Johnson, Medtronic and other companies form the forefront of the industry. They occupy an important position with their strong research and development capabilities, mature production capabilities, and extensive sales network. The focus of competition between enterprises is gradually shifting from simple device performance to the provision of overall solutions, including multiple dimensions such as supporting software, data services, and user experience. Open loop artificial pancreas is a relatively mature product, and its technological development mainly focuses on improving the accuracy, reliability, and user friendliness of the system, while striving to reduce production costs and maintenance complexity. The introduction of intelligent functions and algorithm optimization is changing the user experience of traditional open-loop systems. The development of future biotechnology may bring about new insulin delivery mechanisms, and breakthroughs in materials science may enable longer lasting implantable components, reducing equipment maintenance requirements. The advancement of energy technology may give rise to ultra long battery life or even self powered systems, greatly improving user convenience. New products such as patch insulin delivery devices and wearable integrated devices will further simplify the usage process and reduce interference with patients' daily lives. In addition, integration with the digital health ecosystem, innovation in manufacturing processes, and finding exclusive market positioning are also the development trends of future products.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Open Loop Artificial Pancreas, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Open Loop Artificial Pancreas.
The Open Loop Artificial Pancreas market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Open Loop Artificial Pancreas market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Open Loop Artificial Pancreas manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Insulet
Tandem Diabetes Care
Johnson And Johnson
Abbott Laboratories
Ypsomed
Dexcom
Medtronic
Medtrum Technologies
MicroTech Medical
Sansure Medical
Medlinket Medical Technology
SiBionics
Segment by Type
Basic Insulin Pump System
CGM Insulin Pump Linkage System
Threshold Pause System
Segment by Application
Type 1 Diabetes Management
Type 2 Diabetes Intensive Treatment
Clinical Research Transitional Stage
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Open Loop Artificial Pancreas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Open Loop Artificial Pancreas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Open Loop Artificial Pancreas Market Overview
1.1 Product Definition
1.2 Open Loop Artificial Pancreas by Type
1.2.1 Global Open Loop Artificial Pancreas Market Value Comparison by Type (2024 VS 2031)
1.2.2 Basic Insulin Pump System
1.2.3 CGM Insulin Pump Linkage System
1.2.4 Threshold Pause System
1.3 Open Loop Artificial Pancreas by Application
1.3.1 Global Open Loop Artificial Pancreas Market Value by Application (2024 VS 2031)
1.3.2 Type 1 Diabetes Management
1.3.3 Type 2 Diabetes Intensive Treatment
1.3.4 Clinical Research Transitional Stage
1.4 Global Open Loop Artificial Pancreas Market Size Estimates and Forecasts
1.4.1 Global Open Loop Artificial Pancreas Revenue 2020-2031
1.4.2 Global Open Loop Artificial Pancreas Sales 2020-2031
1.4.3 Global Open Loop Artificial Pancreas Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Open Loop Artificial Pancreas Market Competition by Manufacturers
2.1 Global Open Loop Artificial Pancreas Sales Market Share by Manufacturers (2020-2025)
2.2 Global Open Loop Artificial Pancreas Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Open Loop Artificial Pancreas Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Open Loop Artificial Pancreas, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Open Loop Artificial Pancreas, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Open Loop Artificial Pancreas, Product Type & Application
2.7 Global Key Manufacturers of Open Loop Artificial Pancreas, Date of Enter into This Industry
2.8 Global Open Loop Artificial Pancreas Market Competitive Situation and Trends
2.8.1 Global Open Loop Artificial Pancreas Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Open Loop Artificial Pancreas Players Market Share by Revenue
2.8.3 Global Open Loop Artificial Pancreas Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Open Loop Artificial Pancreas Market Scenario by Region
3.1 Global Open Loop Artificial Pancreas Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Open Loop Artificial Pancreas Sales by Region: 2020-2031
3.2.1 Global Open Loop Artificial Pancreas Sales by Region: 2020-2025
3.2.2 Global Open Loop Artificial Pancreas Sales by Region: 2026-2031
3.3 Global Open Loop Artificial Pancreas Revenue by Region: 2020-2031
3.3.1 Global Open Loop Artificial Pancreas Revenue by Region: 2020-2025
3.3.2 Global Open Loop Artificial Pancreas Revenue by Region: 2026-2031
3.4 North America Open Loop Artificial Pancreas Market Facts & Figures by Country
3.4.1 North America Open Loop Artificial Pancreas Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Open Loop Artificial Pancreas Sales by Country (2020-2031)
3.4.3 North America Open Loop Artificial Pancreas Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Open Loop Artificial Pancreas Market Facts & Figures by Country
3.5.1 Europe Open Loop Artificial Pancreas Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Open Loop Artificial Pancreas Sales by Country (2020-2031)
3.5.3 Europe Open Loop Artificial Pancreas Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Open Loop Artificial Pancreas Market Facts & Figures by Region
3.6.1 Asia Pacific Open Loop Artificial Pancreas Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Open Loop Artificial Pancreas Sales by Region (2020-2031)
3.6.3 Asia Pacific Open Loop Artificial Pancreas Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Open Loop Artificial Pancreas Market Facts & Figures by Country
3.7.1 Latin America Open Loop Artificial Pancreas Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Open Loop Artificial Pancreas Sales by Country (2020-2031)
3.7.3 Latin America Open Loop Artificial Pancreas Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Open Loop Artificial Pancreas Market Facts & Figures by Country
3.8.1 Middle East and Africa Open Loop Artificial Pancreas Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Open Loop Artificial Pancreas Sales by Country (2020-2031)
3.8.3 Middle East and Africa Open Loop Artificial Pancreas Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Open Loop Artificial Pancreas Sales by Type (2020-2031)
4.1.1 Global Open Loop Artificial Pancreas Sales by Type (2020-2025)
4.1.2 Global Open Loop Artificial Pancreas Sales by Type (2026-2031)
4.1.3 Global Open Loop Artificial Pancreas Sales Market Share by Type (2020-2031)
4.2 Global Open Loop Artificial Pancreas Revenue by Type (2020-2031)
4.2.1 Global Open Loop Artificial Pancreas Revenue by Type (2020-2025)
4.2.2 Global Open Loop Artificial Pancreas Revenue by Type (2026-2031)
4.2.3 Global Open Loop Artificial Pancreas Revenue Market Share by Type (2020-2031)
4.3 Global Open Loop Artificial Pancreas Price by Type (2020-2031)
5 Segment by Application
5.1 Global Open Loop Artificial Pancreas Sales by Application (2020-2031)
5.1.1 Global Open Loop Artificial Pancreas Sales by Application (2020-2025)
5.1.2 Global Open Loop Artificial Pancreas Sales by Application (2026-2031)
5.1.3 Global Open Loop Artificial Pancreas Sales Market Share by Application (2020-2031)
5.2 Global Open Loop Artificial Pancreas Revenue by Application (2020-2031)
5.2.1 Global Open Loop Artificial Pancreas Revenue by Application (2020-2025)
5.2.2 Global Open Loop Artificial Pancreas Revenue by Application (2026-2031)
5.2.3 Global Open Loop Artificial Pancreas Revenue Market Share by Application (2020-2031)
5.3 Global Open Loop Artificial Pancreas Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Open Loop Artificial Pancreas Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet Open Loop Artificial Pancreas Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Tandem Diabetes Care
6.3.1 Tandem Diabetes Care Company Information
6.3.2 Tandem Diabetes Care Description and Business Overview
6.3.3 Tandem Diabetes Care Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tandem Diabetes Care Open Loop Artificial Pancreas Product Portfolio
6.3.5 Tandem Diabetes Care Recent Developments/Updates
6.4 Johnson And Johnson
6.4.1 Johnson And Johnson Company Information
6.4.2 Johnson And Johnson Description and Business Overview
6.4.3 Johnson And Johnson Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson And Johnson Open Loop Artificial Pancreas Product Portfolio
6.4.5 Johnson And Johnson Recent Developments/Updates
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Company Information
6.5.2 Abbott Laboratories Description and Business Overview
6.5.3 Abbott Laboratories Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Laboratories Open Loop Artificial Pancreas Product Portfolio
6.5.5 Abbott Laboratories Recent Developments/Updates
6.6 Ypsomed
6.6.1 Ypsomed Company Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ypsomed Open Loop Artificial Pancreas Product Portfolio
6.6.5 Ypsomed Recent Developments/Updates
6.7 Dexcom
6.7.1 Dexcom Company Information
6.7.2 Dexcom Description and Business Overview
6.7.3 Dexcom Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dexcom Open Loop Artificial Pancreas Product Portfolio
6.7.5 Dexcom Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Company Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Medtronic Open Loop Artificial Pancreas Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Medtrum Technologies
6.9.1 Medtrum Technologies Company Information
6.9.2 Medtrum Technologies Description and Business Overview
6.9.3 Medtrum Technologies Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medtrum Technologies Open Loop Artificial Pancreas Product Portfolio
6.9.5 Medtrum Technologies Recent Developments/Updates
6.10 MicroTech Medical
6.10.1 MicroTech Medical Company Information
6.10.2 MicroTech Medical Description and Business Overview
6.10.3 MicroTech Medical Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroTech Medical Open Loop Artificial Pancreas Product Portfolio
6.10.5 MicroTech Medical Recent Developments/Updates
6.11 Sansure Medical
6.11.1 Sansure Medical Company Information
6.11.2 Sansure Medical Description and Business Overview
6.11.3 Sansure Medical Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sansure Medical Open Loop Artificial Pancreas Product Portfolio
6.11.5 Sansure Medical Recent Developments/Updates
6.12 Medlinket Medical Technology
6.12.1 Medlinket Medical Technology Company Information
6.12.2 Medlinket Medical Technology Description and Business Overview
6.12.3 Medlinket Medical Technology Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medlinket Medical Technology Open Loop Artificial Pancreas Product Portfolio
6.12.5 Medlinket Medical Technology Recent Developments/Updates
6.13 SiBionics
6.13.1 SiBionics Company Information
6.13.2 SiBionics Description and Business Overview
6.13.3 SiBionics Open Loop Artificial Pancreas Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SiBionics Open Loop Artificial Pancreas Product Portfolio
6.13.5 SiBionics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Open Loop Artificial Pancreas Industry Chain Analysis
7.2 Open Loop Artificial Pancreas Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Open Loop Artificial Pancreas Production Mode & Process Analysis
7.4 Open Loop Artificial Pancreas Sales and Marketing
7.4.1 Open Loop Artificial Pancreas Sales Channels
7.4.2 Open Loop Artificial Pancreas Distributors
7.5 Open Loop Artificial Pancreas Customer Analysis
8 Open Loop Artificial Pancreas Market Dynamics
8.1 Open Loop Artificial Pancreas Industry Trends
8.2 Open Loop Artificial Pancreas Market Drivers
8.3 Open Loop Artificial Pancreas Market Challenges
8.4 Open Loop Artificial Pancreas Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Roche
Insulet
Tandem Diabetes Care
Johnson And Johnson
Abbott Laboratories
Ypsomed
Dexcom
Medtronic
Medtrum Technologies
MicroTech Medical
Sansure Medical
Medlinket Medical Technology
SiBionics
听
听
*If Applicable.
